German researchers say targeted alpha therapy can provide hope for men with prostate cancer by using a nuclear isotope. Their findings were published in the October issue of The Journal of Nuclear Medicine, in an article that concluded that using the isotope actinium-225 “is tolerable and presents promising antitumor activity” and that repeated treatments “may lead to continuing tumor control.” Actinium-225 is also being used with great success in helping patients newly diagnosed with Acute Myeloid Leukemia. “Actinium-225, an isotope of the element actinium, which is usually found in uranium ores, is proving effective in curing – not just treating […] Read more about Leukemia patients turn to nuclear